{"id":502244,"date":"2020-08-14T13:36:01","date_gmt":"2020-08-14T13:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=502244"},"modified":"2020-08-14T13:36:01","modified_gmt":"2020-08-14T13:36:01","slug":"celiac-disease-epidemiology-forecast-till-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/celiac-disease-epidemiology-forecast-till-2030_502244.html","title":{"rendered":"Celiac Disease Epidemiology Forecast till 2030"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Celiac Disease Epidemiology Forecast till 2030\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Celiac Disease Epidemiology Forecast till 2030\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s  &#8220;Celiac Disease Epidemiology Forecast to 2030&#8242; report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease (CD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/div>\n<p style=\"text-align: justify;\">Celiac Disease (CD) also known as coeliac disease\/non-tropical sprue or gluten-sensitive enteropathy, is defined as a chronic, multiple-organ small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed people. It is a serious autoimmune disorder where the ingestion of gluten leads to damage in the small intestine; it is not an allergy caused by gluten.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/celiac-disease-cd-epidemiology-forecast\" target=\"_blank\"><strong>Celiac Disease Epidemiology Insights&nbsp;<\/strong><\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>The total Celiac Disease&nbsp;prevalent population in 7 MM in 2017 was 6,334,993 &nbsp;<\/strong><\/li>\n<li>The maximum number of cases of Celiac Disease in the United States in 2017 was found in the age group of 19&ndash;39 years was 241,354<\/li>\n<li>\n<p>Type-Specific Celiac Disease&nbsp;Diagnosed Prevalence in the United States in 2017<br \/>Classical &#8211; 178,536<br \/>Non-classical &#8211; 343,847<br \/>Sub-clinical- 138,861&nbsp;<\/p>\n<\/li>\n<li>\n<p>The total prevalent population of Celiac Disease in 2017<br \/>Germany &#8211; 738,357<br \/>the United Kingdom &#8211; 650,676<br \/>Spain &#8211; 421,326 <br \/> Japan &#8211; 65,148<\/p>\n<\/li>\n<li>The cases of Celiac Disease in the United States in 2017\n<ul>\n<li>238,048 &#8211; Males<\/li>\n<li>423,196 &#8211; Females<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/celiac-disease-cd-epidemiology-forecast\" target=\"_blank\"><strong>Celiac Disease&nbsp;Epidemiology Segmentation in 7MM from 2017 to 2030<\/strong><\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalent Population of Celiac Disease<\/li>\n<li>Total Diagnosed Prevalent Population of Celiac Disease<\/li>\n<li>Gender-specific Diagnosed Prevalent Population of Celiac Disease<\/li>\n<li>Type-specific Diagnosed Prevalent Population of Celiac Disease<\/li>\n<li>Age-specific distribution of Celiac Disease\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-epidemiology-forecast\" target=\"_blank\"><strong>Request for sample pages<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-epidemiology-forecast\" target=\"_blank\"><strong>Table of contents<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Celiac Disease (CD)<\/p>\n<p style=\"text-align: justify;\">3. Celiac Disease (CD): Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">3.1. Introduction<\/p>\n<p style=\"text-align: justify;\">3.2. Sign and Symptoms<\/p>\n<p style=\"text-align: justify;\">3.3. Pathophysiology<\/p>\n<p style=\"text-align: justify;\">3.4. Risk Factors<\/p>\n<p style=\"text-align: justify;\">3.5. Diagnosis<\/p>\n<p style=\"text-align: justify;\">4. Patient Journey<\/p>\n<p style=\"text-align: justify;\">5. Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">5.1. Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">5.2. Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">5.3. Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">5.3.1. Celiac Disease (CD) Epidemiology Scenario in the 7MM (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.4. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.4.1. Celiac Disease (CD) Epidemiology Scenario in the United States (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.5. EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.1.1. Celiac Disease (CD) Epidemiology Scenario in Germany (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.2.1. Celiac Disease (CD) Epidemiology Scenario in France (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.3.1. Celiac Disease (CD) Epidemiology Scenario in Italy (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.4.1. Celiac Disease (CD) Epidemiology Scenario in Spain (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">5.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.5.5.1. Celiac Disease (CD) Epidemiology Scenario in the United Kingdom (2017-2030)<\/p>\n<p style=\"text-align: justify;\">5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">5.6.1. Celiac Disease (CD) Epidemiology Scenario in Japan (2017- 2030)<\/p>\n<p style=\"text-align: justify;\">6. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">6.1. Celiac Disease (CD) Treatment and Management<\/p>\n<p style=\"text-align: justify;\">6.2. Celiac Disease (CD) Treatment Algorithm<\/p>\n<p style=\"text-align: justify;\">7. KOL Views<\/p>\n<p style=\"text-align: justify;\">8. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">9. Appendix<\/p>\n<p style=\"text-align: justify;\">9.1. Bibliography<\/p>\n<p style=\"text-align: justify;\">9.2. Report Methodology<\/p>\n<p style=\"text-align: justify;\">10. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">11. Disclaimer<\/p>\n<p style=\"text-align: justify;\">12. About DelveInsight<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=celiac-disease-epidemiology-forecast-till-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=celiac-disease-epidemiology-forecast-till-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Celiac Disease Epidemiology Forecast to 2030&#8242; report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease (CD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/celiac-disease-epidemiology-forecast-till-2030_502244.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,413,403,404],"tags":[],"class_list":["post-502244","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Services","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=502244"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502244\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=502244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=502244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=502244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}